reglab/housing_qa huggingface dataset:
RI Gen L § 23-6.3-7 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-7 - Confidentiality.

§ 23-6.3-7. Confidentiality.(a) It is unlawful for any person to disclose to a third-party the results of an individual's HIV test without the prior written consent of that individual, except for:(1) A licensed laboratory or other healthcare facility that performs HIV tests shall report test results to the healthcare provider who requested the test and to the director.(2) A healthcare provider shall enter HIV test results in the patient's medical record.(3) Notification to the director of the department of children, youth and families, pursuant to subdivision 23-6.3-4(3).(4) As provided in chapter 37.3 of title 5, § 40.1-5-26, §§ 23-6.3-10 and 23-6.3-14 or as otherwise permitted by law.(5) By a healthcare provider to appropriate persons entitled to receive notification of individuals with infectious or communicable diseases pursuant to §§ 23-5-9 and 23-28.36-3.(b) This chapter shall not be construed to interfere with any other federal or state laws or regulations that provide more extensive protection than provided in this chapter for the confidentiality of healthcare information.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-8 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-8 - Protection of records.

§ 23-6.3-8. Protection of records.(a) Providers of health care, public health officials, and any other person who maintains records containing information on HIV test results of individuals are responsible for maintaining full confidentiality of this data and shall take appropriate steps for their protection, including:(1) Keeping records secure at all times and establishing adequate confidentiality safeguards for any records electronically stored;(2) Establishing and enforcing reasonable rules limiting access to these records; and(3) Training persons who handle records in security objectives and technique.(b) The department shall evaluate reports of HIV/AIDS for completeness and potential referrals for service. All case reports shall be kept in a confidential and secure setting. An HIV/AIDS policy and protocol for security shall be developed and implemented by the department for this purpose.(c) The department shall evaluate its procedures for HIV/AIDS reporting on a continuous basis for timeliness, completeness of reporting, and security of confidential information.(d) The department shall develop a protocol that shall be in accordance with the most recent recommendations of the CDC's Guidelines for National Human Immunodeficiency Virus Case Surveillance, including monitoring for Human Immunodeficiency Virus infection and Acquired Immunodeficiency Syndrome, pertaining to patient records and confidentiality; provided, however, that in no event shall the protocol be less protective than that required by state law.(e) All reports and notifications made pursuant to this section shall be confidential and protected from release except under the provisions of law. Any person aggrieved by a violation of this section shall have a right of action in the superior court and may recover for each violation.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-9 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-9 - Penalties and remedies.

§ 23-6.3-9. Penalties and remedies.The penalties and remedies contained in chapter 37.3 of title 5 entitled "Confidentiality of Health Care Communications and Information" shall apply to violations of §§ 23-6.3-7 confidentiality and 23-6.3-8 protection of records.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-10 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-10 - Notification of disclosure.

§ 23-6.3-10. Notification of disclosure.(a) In all cases when an individual's HIV test results are disclosed to a third-party, other than a person involved in the care and treatment of the individual, and except as permitted by § 23-6.3-7 (permitted disclosures re: confidentiality), and permitted by and disclosed in accordance with the Federal Health Insurance Portability and Accountability Act of 1996 (Public law 104-191) enacted on August 21, 1996 and as thereafter amended, the person so disclosing shall make reasonable efforts to inform that individual in advance of:(1) The nature and purpose of the disclosure;(2) The date of disclosure;(3) The recipient of the disclosed information.(b) Healthcare providers may inform third-parties with whom an HIV infected patient is in close and continuous exposure related contact, including, but not limited to a spouse and/or partner, if the nature of the contact, in the healthcare provider's opinion, poses a clear and present danger of HIV transmission to the third-party, and if the physician has reason to believe that the patient, despite the healthcare provider's strong encouragement, has not and will not inform the third-party that they may have been exposed to HIV.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1; P.L. 2010, ch. 239, § 18.
RI Gen L § 23-6.3-11 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-11 - Discrimination prohibited.

§ 23-6.3-11. Discrimination prohibited.No person, agency, organization, or legal entity may discriminate against an individual on the basis of a positive HIV test result, or perception of a positive test, in housing, education, employment, the granting of credit, public accommodation, or delivery of services, nor shall an HIV test be required as a condition of employment.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-12 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-12 - Administrative relief.

§ 23-6.3-12. Administrative relief.Any individual who believes that he or she has been unlawfully discriminated against in housing, education, employment, the granting of credit, public accommodations, or delivery of services on the basis of a positive HIV test, or perception of a positive test, may bring action for administrative relief before the Rhode Island human rights commission; and that commission may hear the matter and grant relief in those cases.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-13 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-13 - HIV Counseling, Testing, Referral and Services Sites (HIV CTRS).

§ 23-6.3-13. HIV Counseling, Testing, Referral and Services Sites (HIV CTRS).The department shall designate and fund HIV CTRS sites, for providing both anonymous and confidential HIV testing and HIV counseling and referral services.Anonymous and confidential HIV testing provided by HIV CTRS sites funded by the department shall screen individuals for their ability to pay for such HIV testing, using a fee schedule and screening process available to the department on request. HIV CTRS sites shall not deny HIV testing to any individual based on his or her inability to pay.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-14 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-14 - Reporting and notification of HIV/AIDS.

§ 23-6.3-14. Reporting and notification of HIV/AIDS.(a) Except in the case of anonymous HIV testing, a diagnosis of HIV or AIDS shall be notifiable and reportable to the department by name.The following shall be reported to the department:(1) A diagnosis of HIV, according to the most current CDC case definition of HIV.(2) A diagnosis of AIDS, according to the most recent CDC case definition of AIDS.(3) A positive ELISA result of any HIV test and/or other FDA approved test indicative of the presence of HIV.(4) Notification of a perinatal exposure to HIV shall be made to the department regardless of confirmatory testing. A perinatal case report for HIV shall be indicated by two (2) positive polymerase chain reaction (PCR) tests; < 18 months; and/or other U.S. Food and Drug Administration approved tests that indicate the presence of HIV in pediatric cases.(b) The following persons shall report information required by this section to the department:(1) A healthcare provider who diagnoses or treats HIV/AIDS;(2) The administrator of a healthcare facility as defined in chapter 17 of this title who diagnoses or treats HIV/AIDS; or(3) The administrator of a prison in which there is an HIV/AIDS infected individual or perinatal exposure to HIV/AIDS.(c) A person responsible for the administration of a clinical or hospital laboratory, blood bank, mobile unit, or other facility in which a laboratory examination of any specimen derived from a human body yields serological, or other evidence of HIV/AIDS, including perinatal exposure to HIV/AIDS shall notify the department in a timely manner.(d) All positive HIV test results shall be confirmed with a Western Blot or other FDA approved confirmatory test.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-15 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-15 - Laboratory analyses and reporting.

§ 23-6.3-15. Laboratory analyses and reporting.(a) All biological samples or specimens taken for the purpose of performing laboratory analysis for the detection of antibody to HIV, by or under the direction or order of any healthcare provider working within the scope of his or her practice, shall be sent to the department of health laboratory for analysis. This provision shall not apply to those HIV tests performed in a hospital laboratory, clinical laboratories as defined in § 23-16.2-2 with testing facilities located in Rhode Island, or to those sites performing rapid HIV testing.(b) Hospitals shall forward all positive confirmatory HIV test results to the department. All sites performing HIV testing must submit an annual HIV testing report to the department in accordance with regulations promulgated by the department.(c) The department laboratory shall conduct all confirmatory testing for HIV/AIDS with the exception of written waivers issued by the department as indicated in subsection (d) below.(d) Sites performing non-venapuncture HIV testing (e.g., rapid testing) must seek a waiver from the department to provide confirmatory HIV testing from a laboratory other than the state laboratory, and shall forward all positive and negative confirmatory HIV tests results to the department.(e) Except in the case of anonymous HIV testing, a healthcare provider working within the scope of his or her practice providing samples of specimens for HIV testing, or results of HIV tests to the department, shall include the name of the patient and other identifying information including information related to the individual's health insurance policy as applicable.(f) Any HIV cases reported in the previous code-based system shall remain in a code-based data set. This does not prohibit a physician from submitting or requesting that an updated name case report on a patient replace a previously coded case report.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1; P.L. 2021, ch. 80, § 1, effective June 24, 2021; P.L. 2021, ch. 81, § 1, effective June 24, 2021.
RI Gen L § 23-6.3-17 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-17 - Rules and regulations.

§ 23-6.3-17. Rules and regulations.The director is authorized to promulgate regulations as he or she deems necessary or desirable to implement the provisions of this chapter, in accordance with the provisions set forth in § 23-1-17 and chapter 35 of title 42.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-18 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-18 - Severability.

§ 23-6.3-18. Severability.If any provision of this chapter is held by a court to be invalid, that invalidity shall not affect the remaining provisions of the chapter, and to this end the provisions of the chapter are declared severable.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.3-19 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.3 - Prevention and Suppression of Contagious Diseases - HIV/AIDS|Section 23-6.3-19 - Construction of the chapter.

§ 23-6.3-19. Construction of the chapter.This chapter shall be liberally construed to accomplish the purposes sought in it.History of Section.P.L. 2009, ch. 196, § 1; P.L. 2009, ch. 289, § 1.
RI Gen L § 23-6.4-1 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-1 - Definitions.

§ 23-6.4-1. Definitions.As used in this chapter:(1) "Administer" means the direct application of an epinephrine auto-injector to the body of an individual.(2) "Authorized entity" means any entity or organization at, or in connection with, where allergens capable of causing anaphylaxis may be present, as identified by the department of health. The department shall, through rule or other guidance, identify the types of entities and organizations that are considered authorized entities no later than January 1, 2015, and shall review and update such rule or guidance at least annually thereafter.(3) "Authorized healthcare provider" means a physician, nurse, or other person duly authorized by law, in the state in which they practice, to prescribe drugs.(4) "Epinephrine auto-injector" means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.(5) "Provide" means the supplying of one or more epinephrine auto-injectors to an individual.(6) "Self-administration" means a person's discretionary use of an epinephrine auto-injector.History of Section.P.L. 2014, ch. 514, § 1.
RI Gen L § 23-6.4-2 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-2 - Prescribing to an authorized entity permitted.

§ 23-6.4-2. Prescribing to an authorized entity permitted.An authorized healthcare provider may prescribe epinephrine auto-injectors in the name of an authorized entity for use in accordance with this section, and pharmacists may dispense epinephrine auto-injectors pursuant to a prescription issued in the name of an authorized entity.History of Section.P.L. 2014, ch. 514, § 1.
RI Gen L § 23-6.4-3 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-3 - Designated entities permitted to maintain supply.

§ 23-6.4-3. Designated entities permitted to maintain supply.An authorized entity may acquire and stock a supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this chapter. Such epinephrine auto-injectors shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injector's instructions for use and any additional requirements that may be established by the department of health. An authorized entity shall designate employees or agents who have completed the training required by § 23-6.4-6 to be responsible for the storage, maintenance, and general oversight of epinephrine auto-injectors acquired by the authorized entity.History of Section.P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.
RI Gen L § 23-6.4-4 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-4 - Use of epinephrine auto-injectors.

§ 23-6.4-4. Use of epinephrine auto-injectors.An employee or agent of an authorized entity, or other individual, who has completed the training required by § 23-6.4-6, may, on the premises of or in connection with the authorized entity, use epinephrine auto-injectors prescribed pursuant to § 23-6.4-2 to:(1) Provide an epinephrine auto-injector to any individual who, the employee, agent, or other individual, believes in good faith is experiencing anaphylaxis, for immediate self-administration, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.(2) Administer an epinephrine auto-injector to any individual who, the employee, agent, or other individual, believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine auto-injector or has previously been diagnosed with an allergy.History of Section.P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.
RI Gen L § 23-6.4-5 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-5 - Expanded availability.

§ 23-6.4-5. Expanded availability.An authorized entity that acquires a stock supply of epinephrine auto-injectors pursuant to a prescription issued in accordance with this chapter, may make such epinephrine auto-injectors available to individuals other than those trained individuals described in § 23-6.4-6, and such individuals may administer such epinephrine auto-injector to any individual believed in good faith to be experiencing anaphylaxis, if the epinephrine auto-injectors are stored in a locked, secure container and are made available only upon remote authorization by an authorized healthcare provider after consultation with the authorized healthcare provider by audio, televideo, or other similar means of electronic communication. Consultation with an authorized healthcare provider for this purpose shall not be considered the practice of telemedicine or otherwise be construed as violating any law or rule regulating the authorized healthcare provider's professional practice.History of Section.P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.
RI Gen L § 23-6.4-6 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-6 - Training.

§ 23-6.4-6. Training.An employee, agent, or other individual described in § 23-6.4-4 must complete an anaphylaxis training program prior to providing or administering an epinephrine auto-injector made available by an authorized entity. Such training shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment, or an entity or individual approved by the department of health. Training may be conducted online or in person and, at a minimum, shall cover:(1) Techniques on how to recognize symptoms of severe allergic reactions, including anaphylaxis;(2) Standards and procedures for the storage and administration of an epinephrine auto-injector; and(3) Emergency follow-up procedures.The entity that conducts the training shall issue a certificate, on a form developed or approved by the department of health, to each person who successfully completes the anaphylaxis training program.History of Section.P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.
RI Gen L § 23-6.4-7 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-7 - Good Samaritan protections.

§ 23-6.4-7. Good Samaritan protections.An authorized entity that possesses and makes available epinephrine auto-injectors and its employees, agents, and other trained individuals; a person who uses an epinephrine auto-injector made available pursuant to § 23-6.4-5; an authorized healthcare provider who prescribes epinephrine auto-injectors to an authorized entity; and an individual or entity that conducts the training described in § 23-6.4-6, shall not be liable for any civil damages that result from the administration or self-administration of an epinephrine auto-injector; the failure to administer an epinephrine auto-injector; or any other act or omission taken pursuant to this chapter; provided, however, this immunity does not apply to acts or omissions constituting gross negligence or willful or wanton conduct. The administration of an epinephrine auto-injector in accordance with this chapter is not the practice of medicine. This section does not eliminate, limit, or reduce any other immunity or defense that may be available under state law. An entity located in this state shall not be liable for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent:(1) Would not have been liable for such injuries or related damages had the provision or administration occurred within this state; or(2) Are not liable for such injuries or related damages under the law of the state in which such provision or administration occurred.History of Section.P.L. 2014, ch. 514, § 1; P.L. 2016, ch. 512, art. 1, § 11.
RI Gen L § 23-6.4-8 (2021)
2021 Rhode Island General Laws|Title 23 - Health and Safety|Chapter 23-6.4 - Life-Saving Allergy Medication - Stock Supply of Epinephrine Auto-Injectors - Emergency Administration|Section 23-6.4-8 - Reporting.

§ 23-6.4-8. Reporting.An authorized entity that possesses and makes available epinephrine auto-injectors shall submit to the department of health, on a form developed by the department of health, a report of each incident on the authorized entity's premises that involves the administration of an epinephrine auto-injector. The department of health shall annually publish a report that summarizes and analyzes all reports submitted to it under this section.History of Section.P.L. 2014, ch. 514, § 1.